Cargando…

New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives Dave Singh

Fixed dose combination (FDC) dual bronchodilators that co-administer a long acting β(2)-adrenoceptor agonist (LABA) and a long acting muscarinic antagonist (LAMA) are a new class of inhaled treatment for chronic obstructive pulmonary disease (COPD). This review focuses on the clinical evidence for t...

Descripción completa

Detalles Bibliográficos
Autor principal: Singh, Dave
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415707/
https://www.ncbi.nlm.nih.gov/pubmed/25377687
http://dx.doi.org/10.1111/bcp.12545